Company Filing History:
5 out of 9 
1 out of 5 Years Active: 2020-2022
Title: Anliang Wang: Innovator in Allergen Protein Research
Introduction
Anliang Wang is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of biomedicine, particularly in the development of recombinant allergen proteins. With a total of 5 patents to his name, Wang's work has the potential to impact allergy treatments and diagnostics.
Latest Patents
Wang's latest patents include innovative methods for producing variant recombinant dermatophagoides pteronyssinus type 1 and type 2 allergen proteins. The first patent focuses on a DNA sequence encoding the Der p1 protein, which has been codon-optimized for enhanced expression. This optimization, along with the addition of an activating element, allows for a higher level of Der p1 expression compared to previous methods, while maintaining biological activity similar to the natural protein. The second patent addresses the Der p2 protein, employing a similar approach to achieve improved expression levels and biological activity.
Career Highlights
Throughout his career, Anliang Wang has worked with notable organizations such as Zonhon Biopharma Institute, Inc. and Gensun Institute of Biomedicine Co., Ltd. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Wang has collaborated with esteemed colleagues, including Bruce Yong Ma and Yu Fan. These partnerships have further enriched his research and development efforts in allergen protein innovation.
Conclusion
Anliang Wang's contributions to the field of allergen protein research demonstrate his commitment to advancing medical science. His innovative patents and collaborations position him as a key figure in the ongoing fight against allergies.